Anti-SARS-CoV-2 Spike Antibody Titers and Neutralizing Antibodies in Vaccinated Rheumatoid Arthritis Patients

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A serological test is used to assess the efficacy of vaccination. It has been reported that anti-SARS-CoV-2 spike (S) and neutralizing antibody (Ab) levels are lower following vaccination i...

Descripción completa

Detalles Bibliográficos
Autores principales: Furukawa, Hiroshi, Oka, Shomi, Higuchi, Takashi, Nakama, Moriyuki, Nagai, Nobuhiro, Tohma, Shigeto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414304/
https://www.ncbi.nlm.nih.gov/pubmed/36016252
http://dx.doi.org/10.3390/vaccines10081365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414304/
https://www.ncbi.nlm.nih.gov/pubmed/36016252
http://dx.doi.org/10.3390/vaccines10081365

Ejemplares similares